Optomagnetic detection of DNA triplex nanoswitches by Minero, Gabriel Khose Antonio et al.
 
 
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: Mar 30, 2019
Optomagnetic detection of DNA triplex nanoswitches
Minero, Gabriel Khose Antonio; Fock, Jeppe; McCaskill, John S; Hansen, Mikkel Fougt
Published in:
The Analyst
Link to article, DOI:
10.1039/c6an02419j
Publication date:
2017
Document Version
Peer reviewed version
Link back to DTU Orbit
Citation (APA):
Minero, G. K. A., Fock, J., McCaskill, J. S., & Hansen, M. F. (2017). Optomagnetic detection of DNA triplex
nanoswitches. The Analyst, 142(4), 582-585. DOI: 10.1039/c6an02419j
  
   
  
 
 
Optomagnetic detection of DNA triplex nanoswitches† 
Gabriel Antonio S. Minero,a,b Jeppe Fock,a John S. McCaskill,b and Mikkel F. Hansena†  
 
 
We report on optomagnetic dose-dependent detection of DNA 
triplex-mediated and pH-switchable clusters of functionalised 
magnetic nanoparticles. 
Polypurine-polypyrimidine sequences can fold into 
triple helical DNA structures forming T-A-T and C-G-C+ 
nucleobase triplets upon protonation of cytosine bases 
at pH ≤ 6.1 The predictable and pH-controlled base 
pairing makes triplex-forming sequences very useful for 
programming chemical reactions,2,3 nanomachines,4,5 
nanostructures,6–8 and hydro-gels.9,10 Switching of pH-
responsive DNA composites can be employed for 
controlled release of targets in delivery systems11,12 and 
in on/off regulation of the nanoscale devices upon 
cyclic alternation of pH values.13 
Further, triplex-forming sequences of DNA are known 
to play a significant role in genetic regulation.14–17 
Conditions favouring triplex binding can be screened 
using fluorescent molecular probes18,19 or by DNA 
mobility shift assays.17 For the latter, the assay time can 
be reduced to 10-15 min using capillary gel 
electrophoresis.3,9 Palindromic homopurine-homopyri-
midine tracts have been shown to cause a pH-
dependent structural transition of a plasmid DNA in 
vivo and have been observed during the initial 
replication of tumor viruses.20 Therefore, dose-
dependent detection of polypurine tracts (PPT) in 
human and viral genomes can contribute to molecular 
diagnostics of genetic biomarkers such as the 
conserved PPT region of HIV-1.21  
Label-free detection of DNA targets has been 
demonstrated with high selectivity and sensitivities in 
the 0.05 - 10 nM range using electrochemical 
biosensors.22 Multi-step DNA processing has further 
decreased sensitivities to the sub-pM range.23,24 
Electrochemical detection of triplex DNA formation of  
double-stranded DNA targets with DNA probes on an 
electrode surface has been demonstrated directly in 
complex sample matrices, such as blood serum, with a 
limit of detection (LOD) of about 10 nM.21 Analysis of 
triplex formation of a PPT target as short as 10 bases 
was demonstrated down to nM concentrations.25  
Nanoscale optical DNA sensing was examined using 
confocal microscopy of light-emitting nanowires 
functionalised with p-DNA resulting in an LOD of 
100 aM.26 Colorimetric detection of DNA based on 
agglutination of gold nanoparticle (NP) was reported 
for target DNA concentrations of 75 nM,27 150 nM,28 
and 3.3 µM.29 The LOD could be reduced to 0.1 pM via 
dark field microscopy imaging.27 The duplex DNA-
induced NP aggregation required 2 h of incubation. For 
triplex DNA hybridisation prolonged incubation times 
of 12 h and 24 h were needed.29,30  
Magnetic nanoparticles (MNPs) are increasingly being 
used for robust solid phase analyte detection,31–33 and 
for delivery of small molecules.34–36 Recently, an 
optomagnetic method to detect agglutination of MNPs 
was proposed and used to detect DNA from different 
pathogenic bacteria after rolling circle amplification33 
as well as to investigate the Cu2+ binding properties of 
metformin.32 The method measures the modulation of 
laser light transmitted through the sample container in 
response to an applied oscillating magnetic field. This 
modulation arises from the coupled magnetic and 
optical anisotropies of the MNPs and is highly sensitive 
to size-changes of the MNPs due to agglutination.33  
Here, we employ the optomagnetic readout principle 
(Fig. 1A) to investigate reversible triplex DNA formation 
(Fig. 1B). A single population of MNPs is functionalised 
with palindromic polypyrimidine DNA oligonucleotides. 
At pH ≤ 6, a triplex structure will form between two 
palindromic polypyrimidine DNA strands situated on 
separate MNPs and a polypurine target DNA in 
suspension. Thus, the presence of the target DNA 
  
  
causes formation of MNP clusters at pH ≤ 6. The 
kinetics of cluster formation is accelerated by 
application of a strong magnetic field (magnetic 
incubation). We show that the magnetic incubation 
combined with the optomagnetic readout reduces the 
assay time to a few minutes (Section S3†). 
Two previously presented setups were used: the first 
setup was adapted for a cuvette37 (Fig. 1A), where pH 
titration was easy to handle; the second setup included 
a fully automated lab-on-a-disc sample handling 
including sequential magnetic incubation and readout 
of up to 18 sample pools.33 In brief, a sinusoidally 
varying external magnetic field modulates the 
transmission of monochromatic light (λ = 405 nm) as 
the MNPs cyclically relax away from and align towards 
the magnetic field direction. The real and imaginary 
components 𝑉𝑉2′ and 𝑉𝑉2′′ of the 2
nd harmonic signal are 
normalised with the average signal, 𝑉𝑉0, to account for 
variations in the incoming light intensity. More 
information about the optomagnetic method can be 
found in Section S1†. Experiments involving switching 
of triplex DNA were carried out in the cuvette setup.  
 
Fig. 1: pH-dependent optomagnetic detection of triplex DNA 
nanoswitches. (A) Setup for optomagnetic monitoring of 
MNP agglutination.37 (B) Optomagnetic detection of pH 
nanoswitches; DNA sequences are listed in Table S1†. (C-D). 
Triplex DNA processing at pH 7.5, 6.0, and 5.0 for 0.2 mg/ml 
MNPs (at intermediate probe density, 50 p-DNA per MNP) in 
the presence of 1 nM target ss DNA. (C) 𝑉𝑉2′/𝑉𝑉0 and (D) 𝑉𝑉2′′/𝑉𝑉0 vs frequency. Magnetic incubation of the mixed 
samples for 2 min in 20 mT magnetic field was used to 
accelerate DNA-mediated agglutination. More information 
about the probe density is given in Fig. S1†.  
As a proof of principle, we first measured the pH 
dependence of the system response at three pH values 
(Fig. 1C-D). The obtained optomagnetic spectra can be 
divided into two regions; one above 50 Hz and one 
below 50 Hz. In 𝑉𝑉2′/𝑉𝑉0 (Fig. 1C), the negative peak 
above 50 Hz corresponds to free MNPs.37,38 Below 
50 Hz, a positive peak in 𝑉𝑉2′/𝑉𝑉0 is observed, which 
arises from clusters with a circumference larger than 
the wavelength. The sign change is due to a change in 
the scattering properties of the larger particles.37 In 
𝑉𝑉2
′′/𝑉𝑉0 (Fig. 1D), the signal  below 50 Hz is composed of 
a negative contribution to the signal from free MNPs 
and positive contributions from MNP clusters.  
For pH decreasing from 7.5 to 5.0, we observed a 
decrease in the negative 𝑉𝑉2′/𝑉𝑉0 peak at about 200 Hz in 
Fig. 1C (depletion of free MNPs) and, correspondingly, 
an increase in the positive signal at f < 50 Hz (formation 
of clusters). Both effects contribute to an increasing 
signal in 𝑉𝑉2′′/𝑉𝑉0 below 10 Hz in Fig 1D. Without 
magnetic incubation, however, the spectra were 
almost identical to that of the no-target sample 
(Fig. S2†). For further analysis, we used the average 
signal ⟨𝑉𝑉2′′/𝑉𝑉0⟩1−10 Hz at f = 1-10 Hz, as this provided 
the largest response to the cluster formation. The 
obtained pH-dependence of the optomagnetic signal 
was consistent with our studies of the triplex switching 
reported previously.3 The nanoswitches between stable 
(pH < 5.5) and unstable (pH > 7.5) conditions for triplex 
formation were observed to behave reversibly and to 
be clearly detectable in the optomagnetic signal (Fig. 
1B). We also investigated real-time detection of 
melting DNA bridges between MNPs and the resulting 
depletion of MNP clusters at low pH (Fig. S3†). The 
obtained trends of optomagnetic signal vs. tempe-
rature were consistent with melting of the triplex DNA 
(broad melting transition at 45-55°C).3   
  
Below, all optomagnetic signals were measured after 
automated magnetic incubation on a disc.33 The 
presence of matching DNA target (0.1-2 nM) revealed 
clustering of MNPs via formation of triplex DNA Y•R•Y 
at conditions favourable for triplex formation (pH 5.0) 
(Fig. 2A). These were seen in the low-frequency 
response as discussed in the previous section and in 
Section S5†. The specificity of the triplex formation was 
investigated using a non-matching DNA for which no 
detectable changes in 𝑉𝑉2′′ were observed (Fig. S4†). 
 
 
Fig. 2: Dose-dependent analysis of optomagnetic signal from 
the MNPs/p-DNA in the presence of matching target DNA. 
(A) Optomagnetic spectra from the sequence specific Y•R•Y 
at pH 5.0. (B) ⟨𝑉𝑉2′′/𝑉𝑉0⟩1−10 Hz  vs. concentration of polypurine 
target DNA. The black line represents the LOD obtained as 
the signal from the no-target sample plus three times its 
standard deviation. See Section S2† for more details on the 
assay. 
It is well known that the gain of DNA sensors is a 
complex function of the capture probe packing 
density.22,39 For the MNP concentration of 0.2 mg/ml, 
we observed the most sensitive detection of target at 
intermediate packing density (50 p-DNA probes per 
MNP), see Fig. S5†. 
Electrochemical biosensors have been applied for label-
free detection of DNA targets at sub-pM concen-
trations, but they require several fabrication steps (4-5 
steps22,23 taking more than 24 h), external stimuli for 
amplification of the signal, e.g., via conformational 
changes of DNA probes on the electrode surface and 
are also sensitive to the liquid properties. The 
presented MNP-based readout has the advantages that 
a sensitive detection scheme can be applied for any 
liquid suspension of the MNPs and that the magnetic 
incubation reduces the assay time to a few minutes 
compared to for example 12 h, which has been 
reported for the assembly of gold nanoparticles.30 
In conclusion, we have demonstrated optomagnetic 
detection of 0.1-2 nM polypurine target DNA via triplex 
folding in the presence of magnetic nanoparticles with 
complementary palindromic DNA probes attached to 
the surface. The strong signal at low frequencies solely 
observed in the presence of the matching target and 
for pH 5, indicates agglutination of the MNPs via triplex 
formation. The obtained MNP clusters can be switched 
by pH, with a reaction time reduced to less than 10 min 
using magnetic incubation. Although our approach is 
limited to homopurine or homopyrimidine triplex-
forming sequences, it can be extended to non-palin-
dromic target and probes by introducing a second 
population of functionalised MNPs according to 
Y1•R•Y2. Targets can be identified as polypurine sub-
sequences of 16-20 bases, which are commonly found 
in human and pathogen genomes.25 Moreover, the 
recognition length of PPTs can even be reduced to 
10 nt by introducing synthetic modifications in the 
probes.40 With this in mind, the approach can be 
extended to be compatible with physiological 
conditions (pH ~ 7).41 
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(#4184-00121B).  
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